Corporate Members

Company Name¡GNovo Nordisk Pharma (Taiwan) Ltd.
Address¡G7F-1, No.216, Sec.2, Tun Hua South Road, Taipei 106, Taiwan, R.O.C. 3, Taipei, Taiwan, R.O.C.
Telephone¡G(02)2377-2566
Fax¡G(02)2377-0111
E-mail ¡GJeng@novo.com.tw
Website¡Gwww.novonordisk.com.tw

General Manager¡GMr. Eric Wang 
Established in¡GJuly 11, 1990  
Working Capital¡GNT$9,000,000 
No. of Employees¡G30


¡@ The New Novo Nordisk is a global niche pharmaceutical company with biotechnology expertise. Novo Nordisk is the world leader in diabetes care. The company commands a 45% market share in the industrialized world insulin market and offers the broadest diabetes care portfolio in the industry, including insulin analogues and leading products within the area of insulin delivery systems. In 1923 led by Nobel Prize winner August Krogh, H.C. Hagedorn and August Kongsted, Novo Nordisk begins production of insulin. 

Major products

¡@¡·Human Monocomponent Insulins 
¡@Rapid-acting insulin - Actrapid HM, Velosulin HM 
¡@Intermediate-acting insulin - Monotard HM (Lente), Insulatard HM (NPH)
¡@Long-acting insulin - Ultratard HM (Lente) 
¡@Pre-mixed insulin - Mixtard 30 HM (30% soluble and 70% isophane insulin) 

¡@¡·Penfill Insulin
¡@* Actrapid HM 
¡@* Protaphane HM (NPH) 
¡@* Mixtard 30, 
¡@* Mixtard 50 

¡@¡·Oral Anti-Diabetic Agents (OAD)
¡@* NovoNorm - for the treatment of people with Type 2 diabetes. 

¡@¡·Hormone Replacement Therapy (HRT)
¡@* Activelle - post-menopausal treatment 
¡@* Trisequens - peri-menopausal treatment 

¡@¡·Human Growth Hormone (hGH)
¡@* Norditropin SimpleXx - liquid hGH in a dedicated pen device 
¡@* Norditropin - freze dried hGH 
¡@* Norditropin Penset 

¡@¡·Factor VII
¡@*NovoSeven - for the treatment of haemophilia in patients who do not respond to coagulation factor replacement therapy due to antibody formation. 
¡öHOME | ¡ôTOP